Toxicology International (Formerly Indian Journal of Toxicology)

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

90-days Repeated Oral Dose Toxicity Study on Jawarish Bisbasa (A Polyherbal Unani Formulation)


Affiliations
1 Department of Pharmacology, Central Research Institute of Unani Medicine, Hyderabad - 500038, Telangana, India
2 Central Council for Research in Unani Medicine, New Delhi - 110058, India
     

   Subscribe/Renew Journal


Jawarish Bisbasa (JBS) is a polyherbal Unani formulation clinically indicated for the treatment of Zof-e-Meda (Stomach Weakness), Zof-e-Hazm (Dyspepsia), Bawaseer Amya (Blind piles), Nafkh-e-Shikam (Flatulence) and Ghasiyan (Nausea). The present study was designed to investigate toxicity of JBS following 90 days repeated oral administration in rats. JBS was orally administered at the dose levels of 1000 and 2000 mg/kg bw/day. The results obtained showed that oral administration of JBS at doses 1000 and 2000 mg/kg bw did not show any significant adverse effects on survival, body weight gain, hematology, clinical biochemistry, gross necropsy and histopathology. Therefore, No-Observed-Adverse-Effect-Level (NOAEL) is found to be greater than 2000 mg/kg body weight.

Keywords

Jawarish Bisbasa, Polyherbal, Toxicity, Unani.
User
Subscription Login to verify subscription
Notifications
Font Size

  • Anonymous. National Formulary of Unani Medicine (NFUM), Part-I. Central Council for Research in Unani Medicine; 2006. p. 98–9.

  • CPCSEA. Standard Operating Procedures for IAEC. New Delhi: Committee for the Purpose of Control and Supervision of Experiments on Animals; 2010. p. 41–2.

  • Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008; 22(3):659–6. PMid: 17942826. https://doi.org/10.1096/fj.07-9574LSF

  • ICH. Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals M3(R2). 2009. https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Multidisciplinary/M3_R2/Step4/M3_R2__Guideline.pdf

  • OECD. Test No. 408: Repeated Dose 90-Day Oral Toxicity Study in Rodents. OECD Publishing; 1998. (OECD Guidelines for the Testing of Chemicals, Section 4).

  • Husain GM, Ahmed S, Azhar M, Siddiqui JI, Waheed MA, Kazmi MH. Comparative toxicity study on classical and modified version of Jawarish Jalinoos (a traditional Unani formulation) in rats. Integr Med Res. 2017; 6(1):66–78. PMid: 28462146 PMCid: PMC5395683. https://doi.org/10.1016/j.imr.2017.01.001

  • Sharwan G, Jain P, Pandey R, Shukla SS. Toxicity profile of traditional herbal medicine. J Ayu Herb Med. 2015; 1(3):81–90.

  • Ifeoma O, Oluwakanyinsol S. Screening of herbal medicines for potential toxicities. New Insights into Toxicity and Drug Testing. InTech, 2013. p. 63–88. PMid: 23375028. http:// dx.doi.org/10.5772/54493 https://doi.org/10.5772/54493

  • Gribaldo L. Haematotoxicology scientific basis and regulatory aspects. Altern Lab Anim 2002; 30(2):111–3. PMid: 12513660. https://doi.org/10.1177/026119290203002S17

  • Olaniyan JM, Muhammad HL, Makun HA, Busari MB, Abdullah AS. Acute and sub-acute toxicity studies of aqueous and methanol extracts of Nelsonia campestris in rats. J Acute Dis 2016; 5(1):62–70. https://doi.org/10.1016/j.joad.2015.08.006

  • Agbaje EO, Adeneye AA, Daramola AO. Biochemical and toxicological studies of aqueous extract of Syzigium aromaticum (L.) Merr. and Perry (Myrtaceae) in rodents. African J Tradit Complement Altern Med. 2009; 6(3): 241–54. PMid: 20448849. https://doi.org/10.4314/ajtcam.v6i3.57162

  • Lawal B, Shittu OK, Oibiokpa FI, Mohammed H, Umar SI, Haruna GM. Antimicrobial evaluation, acute and subacute toxicity studies of Allium sativum. J Acute Dis. 2016; 5(4):296–301. https://doi.org/10.1016/j.joad.2016.05.002

  • Saidu Y, Bilbis LS, Lawal M, Isezuo SA, Hassan SW, Abbas AY. Acute and sub-chronic toxicity studies of crude aqueous extract of Albizzia chevalieri Harms (Leguminosae). Asian J Biochem. 2007; 2:224–36. https://doi.org/10.3923/ajb.2007.224.236

  • Sellers RS, Morton D, Michael B, Roome N, Johnson JK, Yano BL, et al. Society of toxicologic pathology position paper: organ weight recommendations for toxicology studies. Toxicol Pathol. 2007; 35:751–5. PMid: 17849358. https://doi.org/10.1080/01926230701595300

  • Michael B, Yano B, Sellers RS, Perry R, Morton D, Roome N, et al. Evaluation of organ weights for rodent and non-rodent toxicity studies: a review of regulatory guidelines and a survey of current practices. Toxicol Pathol. 2007; 35:742–50. PMid: 17849357. https://doi.org/10.1080/01926230701595292

  • Fuchs TC, Hewitt P. Biomarkers for drug-induced renal damage and nephrotoxicity - an overview for applied toxicology. AAPS J. 2011; 13(4):615–31. PMid: 21969220 PMCid: PMC3231866. https://doi.org/10.1208/s12248-011-9301-x


Abstract Views: 342

PDF Views: 0




  • 90-days Repeated Oral Dose Toxicity Study on Jawarish Bisbasa (A Polyherbal Unani Formulation)

Abstract Views: 342  |  PDF Views: 0

Authors

Mohd Urooj
Department of Pharmacology, Central Research Institute of Unani Medicine, Hyderabad - 500038, Telangana, India
Muskula Anudeep Reddy
Department of Pharmacology, Central Research Institute of Unani Medicine, Hyderabad - 500038, Telangana, India
Mahe Alam
Central Council for Research in Unani Medicine, New Delhi - 110058, India
Munawwar Husain Kazmi
Department of Pharmacology, Central Research Institute of Unani Medicine, Hyderabad - 500038, Telangana, India
Gulam Mohammed Husain
Department of Pharmacology, Central Research Institute of Unani Medicine, Hyderabad - 500038, Telangana, India

Abstract


Jawarish Bisbasa (JBS) is a polyherbal Unani formulation clinically indicated for the treatment of Zof-e-Meda (Stomach Weakness), Zof-e-Hazm (Dyspepsia), Bawaseer Amya (Blind piles), Nafkh-e-Shikam (Flatulence) and Ghasiyan (Nausea). The present study was designed to investigate toxicity of JBS following 90 days repeated oral administration in rats. JBS was orally administered at the dose levels of 1000 and 2000 mg/kg bw/day. The results obtained showed that oral administration of JBS at doses 1000 and 2000 mg/kg bw did not show any significant adverse effects on survival, body weight gain, hematology, clinical biochemistry, gross necropsy and histopathology. Therefore, No-Observed-Adverse-Effect-Level (NOAEL) is found to be greater than 2000 mg/kg body weight.

Keywords


Jawarish Bisbasa, Polyherbal, Toxicity, Unani.

References





DOI: https://doi.org/10.18311/ti%2F2018%2Fv25i4%2F23868